IPO SnapShot

VAISHALI PHARMA LTD.

IPODATE
Aug 07, 2017 TO Aug 10, 2017
LISTINGDATE
8/22/2017 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 10

per share

ISSUESIZE
₹ 14.2272 Cr
PRICEBAND
₹ 71 - ₹ 72

per share

MARKETLOT
1600

shares

OBJECTIVE

The objects to the Issue are as Follows:1. Working Capital Requirements2. General Corporate Purposes

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

No Description found

ADDRESS

Address: 706 To 709
7th Floor
Aravali Busines Center
R. C. Patel Road
Off Sodawala Lane
Borivali (West)
City: Mumbai,
State: Maharashtra
Pincode: 400092
Phone: 022 42171819
Email: investor@vaishalipharma.com / cs@vaishalipharma.com
Website: www.vaishalipharma.com

LISTED AT

NSE

LEAD MANAGER

Pantomath Capital Advisors Pvt Ltd.

PROMOTERS

Atul Vasani
Jagruti Vasani

PROMOTER'S HOLDING

Total Share Capital

Offered to Public

-

Promoter's Holding (Pre-Issue)

Promoter's Holding (Post-Issue)

REGISTRAR

Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.